Report cover image

Pompe Disease Global Market Report 2023 Including: 1) By Type: Classic Infantile Form; Non-Classic Infantile Form; Late-Onset Form 2) By Diagnosis: Blood Test; Genetic Test; Prenatal Test 3) By Route of Administration: Oral; Parenterals 4) By Therapy Type

Publisher The Business Research Company
Published Sep 21, 2023
Length 175 Pages
SKU # BRC18193036

Description

Pompe Disease Global Market Report 2023

Including: 1) By Type: Classic Infantile Form; Non-Classic Infantile Form; Late-Onset Form2) By Diagnosis: Blood Test; Genetic Test; Prenatal Test3) By Route of Administration: Oral; Parenterals4) By Therapy Type: Enzyme Replacement Therapy (ERT); Substrate Reduction Therapy (SRT); Gene Therapy5) By End Users: Hospitals / Clinics; Pharmaceuticals; ResearchersCovering: F. Hoffmann-La Roche AG; Bayer AG; Novartis AG; Sanofi S.A.; Thermo Fisher Scientific Inc.


Pompe Disease Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pompe disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for pompe disease? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pompe disease market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Classic Infantile Form; Non-Classic Infantile Form; Late-Onset Form; Other Types

2) By Diagnosis: Blood Test; Genetic Test; Prenatal Test; Other Diagnosis

3) By Route of Administration: Oral; Parenteral; Other routes of administrations

4) By Therapy Type: Enzyme Replacement Therapy (ERT); Substrate Reduction Therapy (SRT); Gene Therapy, Other Therapies

5) By End Users: Hospitals / Clinics; Pharmaceuticals; Researchers; Other End-Users

Companies Mentioned: F. Hoffmann-La Roche AG; Bayer AG; Novartis AG; Sanofi S.A.; Thermo Fisher Scientific Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Pompe Disease Market Characteristics
3. Pompe Disease Market Trends And Strategies
4. Pompe Disease Market - Macro Economic Scenario
4.1. Impact Of High Inflation On Online Therapy Services Market
4.2. Ukraine-Russia War Impact On Online Therapy Services Market
4.3. COVID-19 Impact On Online Therapy Services Market
5.1. Global Pompe Disease Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
5.2. Global Pompe Disease Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
5.3. Global Pompe Disease Market Drivers and Restraints
5.3.1. Drivers Of The Market
5.3.2. Restraints Of The Market
6. Pompe Disease Market Segmentation
6.1. Global Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Classic Infantile Form
Non-Classic Infantile Form
Late-Onset Form
Other Types
6.2. Global Pompe Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Blood Test
Genetic Test
Prenatal Test
Other Diagnoses
6.3. Global Pompe Disease Market, Segmentation By Routes of Administration, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Oral
Parenteral
Other routes of administration
6.4. Global Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Enzyme Replacement Therapy (ERT)
Substrate Reduction Therapy (SRT)
Gene Therapy
Other Therapies
6.5. Global Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
Hospitals or Clinics
Pharmaceuticals
Researchers
Other End-Users
7. Pompe Disease Market Regional And Country Analysis
7.1. Global Pompe Disease Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Pompe Disease Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Pompe Disease Market
8.1. Asia-Pacific Pompe Disease Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.3. Asia-Pacific Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8.4. Asia-Pacific Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Pompe Disease Market
9.1. China Pompe Disease Market Overview
9.2. China Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.4. China Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Pompe Disease Market
10.1. India Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.3. India Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Pompe Disease Market
11.1. Japan Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.3. Japan Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Pompe Disease Market
12.1. Australia Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.3. Australia Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Pompe Disease Market
13.1. Indonesia Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.3. Indonesia Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Pompe Disease Market
14.1. South Korea Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.3. South Korea Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Pompe Disease Market
15.1. Western Europe Pompe Disease Market Overview
15.2. Western Europe Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.4. Western Europe Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Pompe Disease Market
16.1. UK Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.3. UK Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Pompe Disease Market
17.1. Germany Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.3. Germany Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Pompe Disease Market
18.1. France Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.3. France Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Italy Pompe Disease Market
19.1. Italy Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.2. Italy Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Italy Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Spain Pompe Disease Market
20.1. Spain Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Spain Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.3. Spain Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. Eastern Europe Pompe Disease Market
21.1. Eastern Europe Pompe Disease Market Overview
21.2. Eastern Europe Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. Eastern Europe Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.4. Eastern Europe Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. Russia Pompe Disease Market
22.1. Russia Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.2. Russia Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. Russia Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. North America Pompe Disease Market
23.1. North America Pompe Disease Market Overview
23.2. North America Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. North America Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.4. North America Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. USA Pompe Disease Market
24.1. USA Pompe Disease Market Overview
24.2. USA Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.3. USA Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.4. USA Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Canada Pompe Disease Market
25.1. Canada Pompe Disease Market Overview
25.2. Canada Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Canada Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.4. Canada Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. South America Pompe Disease Market
26.1. South America Pompe Disease Market Overview
26.2. South America Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. South America Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.4. South America Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Brazil Pompe Disease Market
27.1. Brazil Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.2. Brazil Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27.3. Brazil Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28. Middle East Pompe Disease Market
28.1. Middle East Pompe Disease Market Overview
28.2. Middle East Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.3. Middle East Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
28.4. Middle East Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29. Africa Pompe Disease Market
29.1. Africa Pompe Disease Market Overview
29.2. Africa Pompe Disease Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.3. Africa Pompe Disease Market, Segmentation By Therapy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
29.4. Africa Pompe Disease Market, Segmentation By End Users, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
30. Pompe Disease Market Competitive Landscape And Company Profiles
30.1. Pompe Disease Market Competitive Landscape
30.2. Pompe Disease Market Company Profiles
30.2.1. F. Hoffmann-La Roche AG
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Bayer AG
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Novartis AG
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Sanofi S.A.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Thermo Fisher Scientific Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Pompe Disease Market Other Major And Innovative Companies
31.1. Fresenius Kabi AG
31.2. Danaher Corporation
31.3. Becton, Dickinson and Company
31.4. Astellas Pharma Inc.
31.5. BioMérieux SA
31.6. BioMarin Pharmaceutical Inc.
31.7. Nova Biomedical Corporation
31.8. Instrumentation Laboratory Company
31.9. Amicus Therapeutics Inc.
31.10. Sekisui Diagnostics LLC
31.11. Spark Therapeutics Inc.
31.12. Sangamo BioSciences Inc.
31.13. Asklepios BioPharmaceutical Inc.
31.14. Avrobio Inc.
31.15. EKF Diagnostics Holdings plc
32. Global Pompe Disease Market Competitive Benchmarking
33. Global Pompe Disease Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Pompe Disease Market
35. Pompe Disease Market Future Outlook and Potential Analysis
35.1 Pompe Disease Market In 2027 - Countries Offering Most New Opportunities
35.2 Pompe Disease Market In 2027 - Segments Offering Most New Opportunities
35.3 Pompe Disease Market In 2027 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us